FDA Approves Renewal Of Canalevia-CA1

Benzinga · 3d ago

Conditional approval extended through December 2026 for the treatment of CID in dogs

CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled to date; ~49 more expected